Actinium Pharmaceuticals, Inc. Share Price
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:00 05/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.300 USD | -7.80% |
|
-15.03% | -4.41% |
| 10-29 | Top Premarket Decliners | MT |
| 10-23 | Actinium Pharmaceuticals, Inc. Highlights First-In-Human Phase 1 Study of Atnm-400 A Her3-Targeted Non-Psma Radiotherapy in Prostate Cancer At Esmo 2026 | CI |
| Market Cap | 40.87M 36.42M 33.31M 30.34M 57.19M 3.86B 58.73M 400M 160M 2.05B 153M 150M 6.46B | P/E 2026 * |
7.36x | P/E 2027 * | -1.94x |
|---|---|---|---|---|---|
| Enterprise Value | 40.87M 36.42M 33.31M 30.34M 57.19M 3.86B 58.73M 400M 160M 2.05B 153M 150M 6.46B | EV / Sales 2026 * |
1.17x | EV / Sales 2027 * | - |
| Free-Float |
98.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
CBOE
| ATNM | Real-time | |
|
Tradegate
| 7AY1 | Real-time | |
|
Deutsche Boerse AG
| 7AY1 | Delayed | |
|
Börse Stuttgart
| 7AY1 | Delayed | |
|
Boerse Muenchen
| 7AY1 | Real-time |
| 1 day | -7.80% | ||
| 1 week | -15.03% | ||
| Current month | -12.16% | ||
| 1 month | +8.33% | ||
| 3 months | +73.63% | ||
| 6 months | +3.17% | ||
| Current year | -4.41% |
| 1 week | 1.3 |  | 1.53 |
| 1 month | 0.95 | | 1.66 |
| Current year | 0.74 | | 1.66 |
| 1 year | 0.74 | | 1.72 |
| 3 years | 0.74 | | 10.24 |
| 5 years | 0.74 | | 15.12 |
| 10 years | 0.74 | | 51.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 61 | 08/06/2017 |
Mathew David
DFI | Director of Finance/CFO | 49 | 13/10/2026 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Nicholson
BRD | Director/Board Member | 72 | 31/12/2007 |
Sandesh Seth
CHM | Chairman | 61 | 30/09/2013 |
| Director/Board Member | 69 | 07/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Free | Chief Financial Officer | 500,000 | 1.5903% | ||
| 03/09/26 | Other | Chief Technology Officer | 333,648 | 1.0634% | ||
| 03/09/26 | Other | Chief Technology Officer | 403,868 | 1.2872% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.80% | -15.03% | -2.99% | -72.69% | 40.87M | |
| +3.80% | +8.10% | +63.78% | +77.70% | 69.4B | |
| +0.07% | +1.39% | +12.75% | +75.17% | 57.24B | |
| +1.63% | +4.93% | +24.89% | +104.31% | 57.62B | |
| +0.41% | -3.70% | +26.06% | +34.32% | 43.65B | |
| +2.51% | +4.22% | +20.49% | +110.71% | 44.03B | |
| -11.04% | -6.63% | +199.38% | +701.67% | 38.08B | |
| +7.50% | +13.58% | +29.07% | +64.46% | 36.31B | |
| +1.59% | -4.04% | +97.66% | +79.95% | 32.61B | |
| -1.77% | +7.46% | +36.57% | -4.59% | 25.47B | |
| Average | -0.31% | +1.02% | +50.77% | +117.10% | 40.45B | |
| Weighted average by Cap. | +0.86% | +3.11% | +52.89% | +132.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35M 31.19M 28.53M 25.98M 48.97M 3.31B 50.29M 343M 137M 1.75B 131M 129M 5.53B | - |
| Net income | 5.91M 5.27M 4.82M 4.39M 8.27M 559M 8.49M 57.89M 23.15M 296M 22.19M 21.71M 934M | -30.95M -27.58M -25.22M -22.97M -43.3M -2.92B -44.47M -303M -121M -1.55B -116M -114M -4.89B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | US$1.300 | -7.80% | 213,040 |
| 04/11/26 | US$1.410 | +0.71% | 104,261 |
| 03/11/26 | US$1.400 | -2.10% | 75,844 |
| 02/11/26 | US$1.430 | -3.38% | 104,580 |
| 30/10/26 | US$1.480 | -3.27% | 157,720 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions
